Results 121 to 130 of about 65,584 (272)

VAMP7‐mediated autophagy regulates cervical cancer progression associated with persistent HPV16 infection

Clinical and Translational Medicine, Volume 16, Issue 1, January 2026.
Vesicle‐associated membrane protein 7 (VAMP7) plays a pivotal role in HPV16‐driven cervical cancer by regulating autophagy, promoting tumour cell survival, immune evasion and lesion progression. These findings highlight VAMP7 as a potential therapeutic target, offering new opportunities for early intervention and treatment of cervical cancer.
Weijuan Xin, Junjie Zhang, Dan Wu, Yiying Cai, Xue Ding, Lu Zhou, Na Liu, Yue Wang, Zhiling Zhu, Keqin Hua   +9 more
wiley   +1 more source

Identification of five novel germline mutations of the MEN1 gene in Japanese multiple endocrine neoplasia type 1 (MEN1) families. [PDF]

, 1998
Makoto Sato, Seishiro Matsubara, Akira Miyauchi, Hidemi Ohye, Hitomi Imachi, Koji Murao, J Takahara   +6 more
openalex   +1 more source

Natural Products Targeting Notch Signaling in Cancer: Mechanistic Insights and Food‐Based Chemoprevention Potential

Food Frontiers, Volume 7, Issue 1, January 2026.
The Notch signaling pathway plays a dual role in cancer, acting as both a tumor promoter and suppressor depending on cellular context. This review highlights how natural products modulate Notch signaling to inhibit tumor initiation, progression, angiogenesis, and cancer stem cell maintenance.
Rabab Fatima, Parteek Prasher, Mousmee Sharma, Dietrich Büsselberg, Gabriela Figueroa‐González, Octavio Daniel Reyes‐Hernández, Edgar Yebrán Villegas‐Vázquez, Hernán Cortés, Gerardo Leyva‐Gómez, Jesús Herrera‐Bravo, Solomon Habtemariam, Javad Sharifi‐Rad, Monica Butnariu, Cristian Berar, Angela Caunii, William C. Cho   +15 more
wiley   +1 more source

Triage and care for women with symptoms or diagnosis of pregnancy loss between 14 + 0 and 21 + 6 weeks' gestation

International Journal of Gynecology &Obstetrics, Volume 172, Issue 1, Page 25-50, January 2026.
Abstract Mid‐trimester pregnancy loss (MTL), defined as a pregnancy loss occurring between 14 + 0 and 21 + 6 weeks of gestation, causes significant physical and emotional distress to women and presents clinical challenges to healthcare professionals. It is acknowledged that in low‐resource settings, this guideline might be applicable to births up to 28 
Caroline E. Fox, Rosinder Kaur, Kugajeevan Vigneswaran, Rachel Small, Jenny Carter, Keelin O'Donoghue, Alexander E. P. Heazell, Anna L. David, Nigel Simpson, Angharad Care, Lisa Starrs, Andrew Shennan, Catalina María Valencia González, Priya Soma‐Pillay, Leah Fitzsimmons, Adam J. Devall, Arri Coomarasamy, Mid‐trimester Pregnancy Loss Guideline Consensus Panel, Owen Arthurs, Ruth Bender‐Atik, Phil Bennett, Kirstien Boelaert, Elizabeth Bonney, Leanna Brace, Naomi Carlisle, Davide Casagrandi, Manju Chandiramani, Carolyn Chiswick, Alexandra Emms, Stella Fielder, James Goadsby, Laura Goodfellow, Jim Gray, Jemma Johns, Emma Kirk, Will Lester, Sophie Mackay, Maria Memtsa, Katie Morris, Sunbal Mukhtar, Naimah Raza, Rita Sarquis, Neil Sebire, Lucy Smith, Lucy Spencer, Amos Tetteh, Natalie Woodhead   +46 more
wiley   +1 more source

An Unusual Presentation of a Patient with Multiple Endocrine Neoplasia- 1

, 2014
Nitin Kapoor
openalex   +1 more source

Understanding the variant landscape, and genetic epidemiology of Multiple Endocrine Neoplasia in India [PDF]

, 2023
Aastha Vatsyayan, Juhi Bhardwaj, Srashti Jyoti Agrawal, Bhaskar Jyoti Saikia, Arvinden VR, Vigneshwar Senthivel, Suruchi Trehan, Kavita Pandhare, Mohamed Imran, Rahul C. Bhoyar, Mohit Kumar Divakar, Anushree Mishra, Bani Jolly, Sridhar Sivasubbu, Vinod Scaria   +14 more
openalex   +1 more source

MicroRNA Expression in Breast Cancer Patients, an Integrative Review

Journal of Surgical Oncology, Volume 133, Issue 1, Page 31-38, January 2026.
ABSTRACT This integrative review examines the differential expression of miRNAs in breast cancer patients across various disease stages. Through analysis of 42 articles published between 2005 and 2023, the review identifies multiple miRNAs with significant diagnostic, prognostic, and predictive potential in breast cancer management.
Larissa Fernanda Campos Moreira da Silva, Fabiana Pirani Carneiro, Andrea Barretto Motoyama   +2 more
wiley   +1 more source

Evidence for the founder effect of RET533 as the common Greek and Brazilian ancestor spreading multiple endocrine neoplasia 2A

, 2017
Lucas Leite Cunha, Susan C. Lindsey, Maria Inez C. França, Leda Sarika, Alexandra Papathoma, Ilda S. Kunii, Janete M. Cerutti, Magnus R. Dias‐da‐Silva, Maria Alevizaki, Rui M. B. Maciel   +9 more
openalex   +2 more sources

Thyroid Cancer Risk in Patients With Type 2 Diabetes Taking Glucagon‐Like Peptide 1 Receptor Agonists

OTO Open, Volume 10, Issue 1, January-March 2026.
Abstract Objective Glucagon‐like peptide 1 receptor agonists (GLP‐1RA) have shown remarkable results in glycemic control for patients with type 2 diabetes (T2DM). While no association has been made, there is a concern for thyroid cancer (TC) from GLP‐1RA. We aimed to study the 5‐year risk of TC in T2DM patients taking GLP‐1RA.
Bao Y. Sciscent, Hanel W. Eberly, F. Jeffrey Lorenz, David Goldrich, Neerav Goyal, David Goldenberg   +5 more
wiley   +1 more source

Osteoporosis in Multiple Endocrine Neoplasia Type I: A Case Report – Case Report

Türk Osteoporoz Dergisi, 2008
Multiple Endocrine Neoplasia type I (MEN type-I) is a rare autosomal dominant hereditary cancer syndrome presented mostly by tumours of the parathyroids, endocrine pancreas and anterior pituitary.
Kurtuluş Kaya, Ebru Özcan, Sumru Özel
doaj